Tesio, Saturnino .
HRN: 03-34-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/18/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/18/2025
11/25/2025
IV
2.25G
Q8H
Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Guideline Not Available
Initial appropriateness: No Wrong Dose Adjust According To EGFR
Final appropriateness: Yes
Overall appropriateness: Yes